IN THE NEWS

Two Companies Win Biodefense Contracts

As published in Chemical and Engineering News
Business Concentrates
November 7, 2005 Volume 83, Number 45 pp. 12–13

The U.S. government has awarded two contracts related to enzymes as biodefense agents. Genencor International has secured a $2 million contract from the Department of Defense to develop an enzyme-based decontamination product targeting chemical and biological warfare agents. The firm will work with the U.S. Army Edgewood Chemical & Biological Center to develop enzymes capable of decontaminating agents such as mustard gas, anthrax, and botulism. Meanwhile, Lybradyn has been awarded a Phase I SBIR grant from NIH to develop new organophosphorus hydrolases for the biocatalytic degradation of warfare agents and pesticides.

Read the article in Chemical and Engineering News.